Correction: Antisense oligonucleotide targeting TARDBP-EGFR splicing axis inhibits progression of oral squamous cell carcinoma through ABCA1-regulated cholesterol efflux

Nan Ni; Moxu Wang; Zhiran Yuan; Leqi Zhang; Jilin Cai; Qingqing Du; Pengcheng Li; Chang Gao; Hanwen Zhang; Yuancheng Li; Hua Yuan

doi:10.1038/s41368-026-00434-7

International Journal of Oral Science ›› 2026, Vol. 18 ›› Issue (1) :27 DOI: 10.1038/s41368-026-00434-7

Correction

correction

Correction: Antisense oligonucleotide targeting TARDBP-EGFR splicing axis inhibits progression of oral squamous cell carcinoma through ABCA1-regulated cholesterol efflux

Nan Ni ¹^,²
, Moxu Wang ¹^,²
, Zhiran Yuan ¹^,³
, Leqi Zhang ¹^,²
, Jilin Cai ¹^,²
, Qingqing Du ¹^,²
, Pengcheng Li ¹^,²
, Chang Gao ¹^,²
, Hanwen Zhang ¹^,²
, Yuancheng Li ⁴
, Hua Yuan ¹^,²^,⁵^,⁶^,^a

Author information +

History +

PDF

Cite this article

Download citation ▾

Nan Ni, Moxu Wang, Zhiran Yuan, Leqi Zhang, Jilin Cai, Qingqing Du, Pengcheng Li, Chang Gao, Hanwen Zhang, Yuancheng Li, Hua Yuan. Correction: Antisense oligonucleotide targeting TARDBP-EGFR splicing axis inhibits progression of oral squamous cell carcinoma through ABCA1-regulated cholesterol efflux. International Journal of Oral Science, 2026, 18(1): 27 DOI:10.1038/s41368-026-00434-7

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Ni N, Wang M, Yuan Z, Zhang L, Cai J, Du Qet al. . Antisense oligonucleotide targeting TARDBP-EGFR splicing axis inhibits progression of oral squamous cell carcinoma through ABCA1-regulated cholesterol efflux. Int. J. Oral Sci.. 2026, 1810.